Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
07/2004
07/14/2004CN1511827A Process for separating betaine from water solution of betaine chemically synthetic reaction product
07/14/2004CN1511826A Process for synthesizing beta-amino acid using ketone as raw material
07/14/2004CN1157391C Method and intermediate for preparing is-a-oxazole formylamine and its analogue
07/14/2004CN1157367C Method for prepn. of diacyl-chloride
07/13/2004US6762175 Fatty acid derivatives
07/08/2004WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
07/08/2004WO2004046096A3 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics
07/08/2004US20040133033 Amino dicarboxylic acid is reacted with a benzyl alcohol derivative in presence of alkanesulphonic acid, optionally in the presence of a solvent
07/08/2004US20040132998 Compositions and methods for separating amines and amino acids from their counter-enantiomers
07/08/2004US20040132830 Antiproliferative agents; anticancer agents; antiinflammatory agents; autoimmune diseases
07/08/2004US20040132796 Novel intermediates for use in retinoid synthesis
07/08/2004US20040132769 Certain phenylacetic acids and derivatives
07/07/2004EP1435351A1 Highly concentrated aqueous solutions of n,n-dialkylglycines and process for preparation thereof
07/07/2004EP1435232A1 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
07/07/2004CN1510025A Production of monoconfiguration 2-amino-bulyric acid or its derivatives
07/07/2004CN1156482C Spirocyclophophorous amine
07/06/2004US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/06/2004US6759551 Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same
07/06/2004US6759549 Method of preparing amino carboxylic acids
07/06/2004US6759521 Polarization switching to control crystal form
07/01/2004WO2003104430A3 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
07/01/2004WO2003003804A3 Process for the production of optically active 3-phenylisoserine
07/01/2004US20040127747 using as alkylating agents organic carbonates, preferably of the dialkyl, dibenzyl and diallyl types, in the presence of X- or Y-faujasite catalysts exchanged with alkaline metals
07/01/2004US20040127570 inhibitors of protein-tyrosine phosphatases
07/01/2004US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens
07/01/2004US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel
07/01/2004US20040126700 Solvent solubility; quality film coatings; workability
06/2004
06/30/2004EP1432784A1 Compositions comprising photo-labile
06/30/2004EP1432453A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
06/30/2004EP1244611B1 Squaric acid derivatives as integrin antagonists
06/30/2004EP1176137B1 Powdery s,s-ethylenediamine-n,n'-disuccinic acid iron complex and process for producing the same
06/30/2004CN1509267A Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II
06/30/2004CN1508095A Chelated plant micronutrients
06/30/2004CN1155606C Synthesis of chiral phosphine-borane complex and its application in asymmetric hydrogenation
06/30/2004CN1155599C Tricyclic triazolobenzazepine derivatives, process for producing same, and antiallergic agent
06/30/2004CN1155560C Post-extraction process in synthesizing L-phenylalanine via trans-cinnamic acid enzymatic-process
06/29/2004US6756406 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines
06/29/2004US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/29/2004US6755951 Operating in presence of chelate compound that binds multivalent metals; reducing power consumption; preventing membrane fouling
06/29/2004CA2133089C Novel cyclic amino acids and derivatives thereof
06/24/2004WO2004052939A2 Ligands for metals and improved metal-catalyzed processes based thereon
06/24/2004WO2004052850A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
06/24/2004WO2004052844A1 Prodrugs of gaba analogs, compositions and uses thereof
06/24/2004WO2004052837A2 Amino substituted hydroxyphenyl benzophenone derivatives
06/24/2004WO2004052836A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
06/24/2004US20040122254 Selective cyclooxygenase-2(COX-2) inhibitors; free of gastrointestinal side effects; treating eye disorders such as glaucoma or selective cyclooxygenase-2(COX-2) inhibitors, rheumatoid arthritis, arthritis, pain, inflammation
06/24/2004US20040122098 useful for treating conditions which arise from or are exacerbated by angiogenesis and also for treating cancer
06/24/2004US20040121960 For therapy of Alzheimer's and prion disease
06/24/2004US20040121482 by reacting a Bronsted acid with a mixture of a 2-azabicyclo[2.2.1]hept-5-en-3-one and alcohol, forming a salt of cis-4-amino-2-cyclopentene-1-carboxylic acid ester
06/24/2004US20040118318 Alkylamine derivatives as antifouling agents
06/24/2004DE10219851B4 Verfahren zur Herstellung von L-Serin A process for preparing L-serine
06/24/2004CA2508619A1 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
06/24/2004CA2507669A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
06/23/2004EP1431276A1 Preparation and purification of hydroxylamine stabilizers
06/23/2004EP1431274A1 Synthesis of mono-N-substituted functionalized anilines
06/23/2004EP1431267A1 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
06/23/2004EP1430893A1 Stable gabapentin containing more than 20 ppm of chloride ion
06/23/2004EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf
06/23/2004CN1506350A Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll
06/22/2004US6753446 Synthesis of labeled oxalic acid derivatives
06/22/2004US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries
06/22/2004CA2179418C Pesticides
06/17/2004WO2004050664A1 Method for preparation of amino acid chelate
06/17/2004WO2004013282A3 Bis (amino acid) molecular scaffolds
06/17/2004US20040116735 Preparation and purification of hydroxylamine stabilizers
06/17/2004US20040115571 Siver halide emulsion on support ; stability; antistatic agents
06/16/2004EP1428816A1 Method for the manufacture of dodecyl 2-(n,n-dimethylamino)-propionate
06/16/2004EP1427704A1 Method for producing 4-haloalkylnicotinic acid esters
06/16/2004EP1294364A4 Stable gabapentin having ph within a controlled range
06/16/2004EP1268387B1 Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators
06/16/2004EP1110943B1 6-fluorobicyclo 3. 1.0]hexane derivatives
06/16/2004EP0977725B1 New fatty acid derivatives
06/16/2004CN1505606A Production of 6-aminocaproic acid
06/16/2004CN1505601A Novel atisane compound and use thereof
06/16/2004CN1504457A Synthetic method for Nª‡-9-fluorenylmethyloxycarbonyl-amino acid
06/16/2004CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds
06/15/2004US6750369 Substituted amino acids as erythropoietin mimetics
06/15/2004US6750364 For prophylaxis and therapy of schizophrenia, schizoaffective disorder and schizophreniform disorder, cognitive deficits due to aging, stroke, alzheimer's disease or other neurodegenerative diseases
06/15/2004US6750349 Superior gastrokinetic properties
06/15/2004US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
06/15/2004US6750238 Aralkyl ester soft drugs
06/15/2004US6750236 Cardiovascular disorders
06/15/2004US6750171 Synthesis of P-chiral bisphospholane ligands and their transition metal complexes for use as asymmetric hydrogenation catalysts
06/10/2004WO2004048314A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
06/10/2004WO2004047751A2 Calcilytic compounds
06/10/2004WO2004047615A2 Hemiasterlin affinity probes and their uses
06/10/2004WO2004003331A3 Non-corrosive amphoteric surfactants and method of well treatment
06/10/2004WO2003101952A3 Polyamine-mediated transfection
06/10/2004US20040110982 Process for preparing single enantiomers of 5,5,5,5',5',5'-hexafluoroleucine and protected analogs
06/10/2004US20040110840 Novel derivatives of dicarboxylic acid having pharmaceutical properties
06/10/2004US20040110839 Compounds and compositions for delivering active agents
06/10/2004CA2507458A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
06/09/2004EP1426044A1 Use of esters of L-carnitine or alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds
06/09/2004EP1007504B1 Sterilized 5-aminolevulinic acid
06/09/2004CN1503779A Production of alkyl 6-aminocaproate
06/09/2004CN1152854C Preparation of tri-iodo benzene compound
06/09/2004CN1152853C Process for preparing glycine
06/08/2004US6747169 Fluorine compound and surfactant can impart surface functions such as water and oil repelling properties as well as antistatic and antifouling properties
06/08/2004US6747157 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives
06/08/2004US6747143 Methods for polymer synthesis